153
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Novel Insights Toward Human Stroke-Related Epigenetics: Circular RNA and its Impact in Poststroke Processes

, , , , , , & ORCID Icon show all
Pages 1957-1968 | Received 31 Mar 2020, Accepted 18 Sep 2020, Published online: 26 Nov 2020

References

  • Mukherjee D , PatilCG. Epidemiology and the global burden of stroke. World Neurosurg.76(6), S85–S90 (2011).
  • Meschia JF , BushnellC , Boden-AlbalaBet al. Guidelines for the primary prevention of stroke. Stroke45(12), 3754–3832 (2014).
  • Hu X , SilvaTMD , ChenJ , FaraciFM. Cerebral vascular disease and neurovascular injury in ischemic stroke. Circ. Res.120(3), 449–471 (2017).
  • Wang S-W , LiuZ , ShiZ-S. Non-Coding RNA in acute ischemic stroke: mechanisms, biomarkers and therapeutic targets. Cell Transplant.27(12), 1763–1777 (2018).
  • Mehta SL , PandiG , VemugantiR. Circular RNA expression profiles alter significantly in mouse brain after transient focal ischemia. Stroke48(9), 2541–2548 (2018).
  • Wilusz JE . A 360° view of circular RNAs: from biogenesis to functions. Wiley Interdiscip. Rev. RNA9(4), e1478 (2018).
  • Minghon L . Circular RNA: functions, applications and prospects. ExRNA2(1), 1–7 (2020).
  • Ashwal-Fluss R , MeyerM , PamudurtiNR. circRNA Biogenesis Competes with Pre-mRNA splicing. Mol. Cell56(1), 55–66 (2014).
  • Ostolaza A , Blanco-LuquinI , Urdánoz-CasadoA. Circular RNA expression profile in blood according to ischemic stroke etiology. Cell&Bioscience10(1), 1–12 (2020).
  • Limborska SA , FilippenkovIB. Circular RNA as a prospective molecular tool for the study of neuroprotection in cerebral ischemia. Transl. Cancer Res.8(2), 126–129 (2018).
  • Huttner HB , BergmannO , SalehpourM. The age and genomic integrity of neurons after cortical stroke in humans. Nat. Neurosci.17(6), 801–803 (2014).
  • Chandran R , MehtaSL , VemugantiR. Non-coding RNAs and neuroprotection after acute CNS injuries. Neurochem. Int.111, 12–22 (2017).
  • Mehta SL , VemugantiR. Ischemic stroke alters the expression of the transcribed ultraconserved regions of the genome in rat brain. Stroke49(4), 1024–1028 (2018).
  • Han B , ChaoJ , YaoH. Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol. Therapeut.187, 31–44 (2018).
  • Bai Y , ZhangY , HanB. Circular RNA DLGAP4 ameliorates ischemic stroke outcomes by targeting miR-143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity. J. Neurosci.38(1), 32–50 (2017).
  • Zhu X , DingJ , WangB , WangJ , XuM. Circular RNA DLGAP4 is down-regulated and negatively correlates with severity, inflammatory cytokine expression and pro-inflammatory gene miR-143 expression in acute ischemic stroke patients. Int. J. Clin. Exp. Patho.12(3), 941–948 (2019).
  • Han B , ZhangY , ZhangY. Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke. Autophagy14(7), 1164–1184 (2018).
  • Peng X , JingP , ChenJ , XuL. The role of circular RNA HECTD1 expression in disease risk, disease severity, inflammation, and recurrence of acute ischemic stroke. J. Clin. Lab. Anal.33(7), 1–7 (2019).
  • Scott H , PaninVM. Glycobiology of the Nervous System.Springer, New York, USA, 367–394 (2014).
  • Swardfager W , WinerDA , HerrmannN , WinerS , LanctôtKL. Interleukin-17 in post-stroke neurodegeneration. Neurosci. Biobehav. Rev.37(3), 436–447 (2013).
  • Nussbacher JK , TabetR , YeoGW , Lagier-TourenneC. Disruption of RNA metabolism in neurological diseases and emerging therapeutic interventions. Neuron102(2), 294–320 (2019).
  • Singh RK , CooperTA. Pre-mRNA splicing in disease and therapeutics. Trends Mol. Med.18(8), 472–482 (2012).
  • Zhang J , LieuYK , AliAM. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities. Proc. Natl Acad. Sci.112(34), 4726–4734 (2015).
  • Hammond SM . An overview of microRNAs. Adv. Drug Deliver. Rev.87, 3–14 (2015).
  • Moore L , RajpalG , DillinghamI. Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models. mol ther. Nucleic Acids7, 200–210 (2017).
  • Okubadejo N , BrittonA , CrewsC. Analysis of Nigerians with apparently sporadic parkinson disease for mutations in LRRK2,PRKN and ATXN3. PLoSONE3(10), 1–4 (2008).
  • Zhang S , NapieralaM , NapieralaJ. Therapeutic prospects for Friedreich’s ataxia. Trends Pharmacol. Sci.40(4), 229–233 (2019).
  • Choi S , HanN , JungS , KimH , EomM , BaeH. Evaluation of ataxia in mild ischemic stroke patients using the scale for the assessment and rating of ataxia (SARA). Ann. Rehabilitation Medicine42(3), 375–383 (2018).
  • Mariotti C , FancelluR , DonatoSD. An overview of the patient with ataxia. J. Neurol.252(5), 511–518 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.